CASP2 and B-cell non-Hodgkin lymphoma: The lack of clinical correlation with Megf6 expression in B-cell lymphoma may be indicative of a tissue-specific function for Megf6 and/or that Casp2 loss can cooperate with high Megf6 expression to augment lymphomagenesis in the EμMyc/Casp2−/− model.